Enfusion, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Enfusion, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q3 2024.
  • Enfusion, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $1.42M, a 22.6% decline year-over-year.
  • Enfusion, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $3.33M, a 43.6% decline year-over-year.
  • Enfusion, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $6.03M.
  • Enfusion, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$7.65M, a 95.2% increase from 2021.
  • Enfusion, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$158M, a 3998% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $3.33M $1.42M -$413K -22.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $3.74M $1.83M +$1.2M +190% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $2.54M -$539K -$3.48M -118% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $6.03M $623K +$129K +26.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $5.9M $1.83M +$289K +18.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $5.61M $629K +$3.05M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $2.56M $2.95M +$10.2M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$7.65M $494K +$170M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$178M $1.54M -$1.75M -53.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$176M -$2.42M -$6.67M -157% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$170M -$7.27M -$11.4M -277% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$158M -$170M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 $3.29M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $4.25M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $4.11M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.